Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline smoking cessation program before elective surgery
2009-010173-20Phase 4Terminated
- Sponsor
- Pfizer
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of varenicline in nicotine dependence, sponsored by Pfizer. Primary endpoints: Feasibility composite endpoint, Incidence of surgical site infection by CDC definition and 10 more. Started Jul 2009; status: terminated.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on 2009-010173-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010173-20.